Multi-Cancer Early Detection Screening at Rx ReLeaf – Featuring the Galleri Test
The Galleri multi-cancer early detection test looks for certain DNA methylation patterns in a blood sample that may be associated with cancer. If a cancer signal is detected, the test predicts a likely cancer signal origin to help guide additional diagnostic evaluation.
Important: Galleri is a screening test, not a diagnosis. It is not cleared or approved by the U.S. Food and Drug Administration. It may not detect every cancer, and false-positive and false-negative results can occur.

